TY - JOUR AU - Sujobert, P. AU - Salles, G. AU - Bachy, E. PY - 2016 DA - 2016// TI - Molecular classification of diffuse large B-cell lymphoma: what is clinically relevant? JO - HematolOncolClin North Am VL - 30 UR - https://doi.org/10.1016/j.hoc.2016.07.001 DO - 10.1016/j.hoc.2016.07.001 ID - Sujobert2016 ER - TY - JOUR AU - Di Rocco, A. AU - De Angelis, F. AU - Ansuinelli, M. AU - Foà, R. AU - Martelli, M. PY - 2017 DA - 2017// TI - Is now the time for molecular driven therapy for diffuse large B-cell lymphoma? JO - Expert Rev Hematol VL - 10 UR - https://doi.org/10.1080/17474086.2017.1356714 DO - 10.1080/17474086.2017.1356714 ID - Di Rocco2017 ER - TY - JOUR AU - Chaganti, S. AU - Illidge, T. AU - Barrington, S. AU - Mckay, P. AU - Linton, K. AU - Cwynarski, K. PY - 2016 DA - 2016// TI - British Committee for Standards in Haematology. Guidelines for the management of diffuse large B-cell lymphoma JO - Br J Haematol VL - 174 UR - https://doi.org/10.1111/bjh.14136 DO - 10.1111/bjh.14136 ID - Chaganti2016 ER - TY - JOUR AU - Martelli, M. AU - Ferreri, A. J. AU - Agostinelli, C. AU - Di Rocco, A. AU - Pfreundschuh, M. AU - Pileri, S. A. PY - 2013 DA - 2013// TI - Diffuse large B-cell lymphoma JO - CritRevOncol VL - 87 ID - Martelli2013 ER - TY - JOUR AU - Tilly, H. AU - Gomes da Silva, M. AU - Vitolo, U. AU - Jack, A. AU - Meignan, M. AU - Lopez-Guillermo, A. PY - 2015 DA - 2015// TI - Diffuse large B-cell lymphoma (DLBCL): ESMO clinical practice guidelines for diagnosis, treatment and follow-up JO - Ann Oncol VL - 26 UR - https://doi.org/10.1093/annonc/mdv304 DO - 10.1093/annonc/mdv304 ID - Tilly2015 ER - TY - JOUR AU - Li, S. AU - Young, K. H. AU - Medeiros, L. J. PY - 2018 DA - 2018// TI - Diffuse large B-cell lymphoma JO - Pathology VL - 50 UR - https://doi.org/10.1016/j.pathol.2017.09.006 DO - 10.1016/j.pathol.2017.09.006 ID - Li2018 ER - TY - JOUR AU - Alizadeh, A. A. AU - Eisen, M. B. AU - Davis, R. E. AU - Ma, C. AU - Lossos, I. S. AU - Rosenwald, A. PY - 2000 DA - 2000// TI - Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling JO - Nature VL - 403 UR - https://doi.org/10.1038/35000501 DO - 10.1038/35000501 ID - Alizadeh2000 ER - TY - JOUR AU - Rosenwald, A. AU - Wright, G. AU - Chan, W. C. AU - Connors, J. M. AU - Campo, E. AU - Fisher, R. I. PY - 2002 DA - 2002// TI - The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma JO - N Engl J Med VL - 346 UR - https://doi.org/10.1056/NEJMoa012914 DO - 10.1056/NEJMoa012914 ID - Rosenwald2002 ER - TY - JOUR AU - Hans, C. P. AU - Weisenburger, D. D. AU - Greiner, T. C. AU - Gascoyne, R. D. AU - Delabie, J. AU - Ott, G. PY - 2004 DA - 2004// TI - Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray JO - Blood VL - 103 UR - https://doi.org/10.1182/blood-2003-05-1545 DO - 10.1182/blood-2003-05-1545 ID - Hans2004 ER - TY - JOUR AU - Horn, H. AU - Ziepert, M. AU - Becher, C. AU - Barth, T. F. E. AU - Heinz-Wolfram, B. AU - Feller, A. C. PY - 2013 DA - 2013// TI - MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma JO - Blood VL - 121 UR - https://doi.org/10.1182/blood-2012-06-435842 DO - 10.1182/blood-2012-06-435842 ID - Horn2013 ER - TY - JOUR AU - Friedberg, J. W. PY - 2017 DA - 2017// TI - How I treat double-hit lymphoma JO - Blood VL - 130 UR - https://doi.org/10.1182/blood-2017-04-737320 DO - 10.1182/blood-2017-04-737320 ID - Friedberg2017 ER - TY - JOUR AU - Onaindia, A. AU - Medeiros, L. J. AU - Patel, K. P. PY - 2017 DA - 2017// TI - Clinical utility of recently identified diagnostic, prognostic, and predictive molecular biomarkers in mature B-cell neoplasms JO - Mod Pathol VL - 30 UR - https://doi.org/10.1038/modpathol.2017.58 DO - 10.1038/modpathol.2017.58 ID - Onaindia2017 ER - TY - JOUR AU - Rossi, D. AU - Diop, F. AU - Spaccarotella, E. AU - Monti, S. AU - Zanni, M. AU - Rasi, S. PY - 2017 DA - 2017// TI - Diffuse large B-cell lymphoma genotyping on the liquid biopsy JO - Blood VL - 129 UR - https://doi.org/10.1182/blood-2016-05-719641 DO - 10.1182/blood-2016-05-719641 ID - Rossi2017 ER - TY - JOUR AU - Roschewski, M. AU - Dunleavy, K. AU - Pittaluga, S. AU - Moorhead, M. AU - Pepin, F. AU - Kong, K. PY - 2015 DA - 2015// TI - Circulating tumour DNA and CT monitoring in patients with untreated diffuse large B-cell lymphoma: a correlative biomarker study JO - Lancet Oncol VL - 16 UR - https://doi.org/10.1016/S1470-2045(15)70106-3 DO - 10.1016/S1470-2045(15)70106-3 ID - Roschewski2015 ER - TY - JOUR AU - Kurtz, D. M. AU - Green, M. R. AU - Bratman, S. V. AU - Scherer, F. AU - Liu, C. L. AU - Kunder, C. A. PY - 2015 DA - 2015// TI - Noninvasive monitoring of diffuse lerge B-cell lymphoma by immunoglobulin high-throughput sequencing JO - Blood VL - 125 UR - https://doi.org/10.1182/blood-2015-03-635169 DO - 10.1182/blood-2015-03-635169 ID - Kurtz2015 ER - TY - JOUR AU - Ma, R. AU - Jiang, T. AU - Kang, X. PY - 2012 DA - 2012// TI - Circulating microRNAs in cancer: origin, function and application JO - J Exp Clin Cancer Res VL - 31 UR - https://doi.org/10.1186/1756-9966-31-38 DO - 10.1186/1756-9966-31-38 ID - Ma2012 ER - TY - JOUR AU - Regazzo, G. AU - Terrenato, I. AU - Spagnuolo, M. AU - Carosi, M. AU - Cognetti, G. AU - Cicchillitti, L. PY - 2016 DA - 2016// TI - A restricted signature of serum miRNAs distinguishes glioblastoma from lower grade gliomas JO - J Exp Clin Cancer Res VL - 35 UR - https://doi.org/10.1186/s13046-016-0393-0 DO - 10.1186/s13046-016-0393-0 ID - Regazzo2016 ER - TY - JOUR AU - Alencar, A. J. AU - Malumbres, R. AU - Kozloski, G. A. AU - Advani, R. AU - Talreja, N. AU - Chinichian, S. PY - 2011 DA - 2011// TI - MicroRNAs are independent predictors of outcome in diffuse large B-cell lymphoma patients treated with R-CHOP JO - Clin Cancer Res VL - 17 UR - https://doi.org/10.1158/1078-0432.CCR-11-0224 DO - 10.1158/1078-0432.CCR-11-0224 ID - Alencar2011 ER - TY - JOUR AU - Zheng, Z. AU - Xu, P. P. AU - Wang, L. AU - Zhao, H. J. AU - Weng, X. Q. AU - Zhong, H. J. PY - 2017 DA - 2017// TI - MiR21 sensitized B-lymphoma cells to ABT-199 via ICOS/ICOSL-mediated interaction of Treg cells with endothelial cells JO - J Exp Clin Cancer Res VL - 36 UR - https://doi.org/10.1186/s13046-017-0551-z DO - 10.1186/s13046-017-0551-z ID - Zheng2017 ER - TY - JOUR AU - Ni, H. AU - Tong, R. AU - Zou, L. AU - Song, G. AU - Cho, W. C. PY - 2016 DA - 2016// TI - MicroRNAs in diffuse large B-cell lymphoma JO - Oncol Lett VL - 11 UR - https://doi.org/10.3892/ol.2015.4064 DO - 10.3892/ol.2015.4064 ID - Ni2016 ER - TY - JOUR AU - Marques, S. C. AU - Laursen, M. B. AU - Bødker, J. S. AU - Kjeldsen, M. K. AU - Falgreen, S. AU - Schmitz, A. PY - 2015 DA - 2015// TI - Micro-RNAs in B-cells: from normal differentiation to treatment of malignancies JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.3057 DO - 10.18632/oncotarget.3057 ID - Marques2015 ER - TY - JOUR AU - Musilova, K. AU - Mraz, M. PY - 2015 DA - 2015// TI - MicroRNAs in B-cell lymphomas: how a complex biology gets more complex JO - Leukemia VL - 29 UR - https://doi.org/10.1038/leu.2014.351 DO - 10.1038/leu.2014.351 ID - Musilova2015 ER - TY - JOUR AU - Lim, E. L. AU - Trinh, D. L. AU - Scott, D. W. AU - Chu, A. AU - Krzywinski, M. AU - Zhao, Y. PY - 2015 DA - 2015// TI - Comprehensive miRNA sequence analysis reveals survival differences in diffuse large B-cell lymphoma patients JO - Genome Biol VL - 16 UR - https://doi.org/10.1186/s13059-014-0568-y DO - 10.1186/s13059-014-0568-y ID - Lim2015 ER - TY - JOUR AU - Iqbal, J. AU - Shen, Y. AU - Huang, X. AU - Liu, Y. AU - Wake, L. AU - Liu, C. PY - 2015 DA - 2015// TI - Global microRNA expression profiling uncovers molecular markers for classification and prognosis in aggressive B-cell lymphoma JO - Blood VL - 125 UR - https://doi.org/10.1182/blood-2014-04-566778 DO - 10.1182/blood-2014-04-566778 ID - Iqbal2015 ER - TY - JOUR AU - Roehle, A. AU - Hoefig, K. P. AU - Repsilber, D. AU - Thorns, C. AU - Ziepert, M. AU - Wesche, K. O. PY - 2008 DA - 2008// TI - MicroRNA signatures characterize diffuse large B-cell lymphomas and follicular lymphomas JO - Br J Haematol VL - 142 UR - https://doi.org/10.1111/j.1365-2141.2008.07237.x DO - 10.1111/j.1365-2141.2008.07237.x ID - Roehle2008 ER - TY - JOUR AU - Lawrie, C. H. AU - Soneji, S. AU - Marafioti, T. AU - Cooper, C. D. AU - Palazzo, S. AU - Paterson, J. C. PY - 2007 DA - 2007// TI - MicroRNA expression distinguishes between germinal center B cell-like and activated B cell-like subtypes of diffuse large B cell lymphoma JO - Int J Cancer VL - 121 UR - https://doi.org/10.1002/ijc.22800 DO - 10.1002/ijc.22800 ID - Lawrie2007 ER - TY - JOUR AU - Jung, I. AU - Aguiar, R. C. PY - 2009 DA - 2009// TI - MicroRNA-155 expression and outcome in diffuse large B-cell lymphoma JO - Br J Haematol VL - 144 UR - https://doi.org/10.1111/j.1365-2141.2008.07424.x DO - 10.1111/j.1365-2141.2008.07424.x ID - Jung2009 ER - TY - JOUR AU - Lawrie, C. H. AU - Gal, S. AU - Dunlop, H. M. AU - Pushkaran, B. AU - Liggins, A. P. AU - Pulford, K. PY - 2008 DA - 2008// TI - Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma JO - Br J Haematol VL - 141 UR - https://doi.org/10.1111/j.1365-2141.2008.07077.x DO - 10.1111/j.1365-2141.2008.07077.x ID - Lawrie2008 ER - TY - JOUR AU - Chen, W. AU - Wang, H. AU - Chen, H. AU - Liu, S. AU - Lu, H. AU - Kong, D. PY - 2014 DA - 2014// TI - Clinical significance and detection of microRNA-21 in serum of patients with diffuse large B-cell lymphoma in Chinese population JO - Eur J Haematol VL - 92 UR - https://doi.org/10.1111/ejh.12263 DO - 10.1111/ejh.12263 ID - Chen2014 ER - TY - JOUR AU - Li, J. AU - Fu, R. AU - Yang, L. AU - Tu, W. PY - 2015 DA - 2015// TI - miR-21 expression predicts prognosis in diffuse large B-cell lymphoma JO - Int J Clin Exp Pathol VL - 8 ID - Li2015 ER - TY - JOUR AU - Song, G. AU - Gu, L. AU - Li, J. AU - Tang, Z. AU - Liu, H. AU - Chen, B. PY - 2014 DA - 2014// TI - Serum microRNA expression profiling predict response to R-CHOP treatment in diffuse large B cell lymphoma patients JO - Ann Hematol VL - 93 UR - https://doi.org/10.1007/s00277-014-2111-3 DO - 10.1007/s00277-014-2111-3 ID - Song2014 ER - TY - JOUR AU - Yuan, W. X. AU - Gui, Y. X. AU - Na, W. N. AU - Chao, J. AU - Yang, X. PY - 2016 DA - 2016// TI - Circulating microRNA-125b and microRNA-130a expression profiles predict chemoresistance to R-CHOP in diffuse large B-cell lymphoma patients JO - Oncol Lett VL - 11 UR - https://doi.org/10.3892/ol.2015.3866 DO - 10.3892/ol.2015.3866 ID - Yuan2016 ER - TY - JOUR AU - Beheshti, A. AU - Vanderburg, C. AU - McDonald, J. T. AU - Ramkumar, C. AU - Kadungure, T. AU - Zhang, H. PY - 2017 DA - 2017// TI - A circulating microRNA signature predicts age-based development of lymphoma JO - PLoS One VL - 12 UR - https://doi.org/10.1371/journal.pone.0170521 DO - 10.1371/journal.pone.0170521 ID - Beheshti2017 ER - TY - JOUR AU - Swerdlow, S. H. AU - Campo, E. AU - Pileri, S. A. AU - Harris, N. L. AU - Stein, H. AU - Siebert, R. PY - 2016 DA - 2016// TI - The 2016 revision of the World Health Organization classification of lymphoid neoplasms JO - Blood VL - 127 UR - https://doi.org/10.1182/blood-2016-01-643569 DO - 10.1182/blood-2016-01-643569 ID - Swerdlow2016 ER - TY - JOUR AU - Cheson, B. D. AU - Fisher, R. I. AU - Barrington, S. F. AU - Cavalli, F. AU - Schwartz, L. H. AU - Zucca, E. PY - 2014 DA - 2014// TI - Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: the Lugano classification JO - J Clin Oncol VL - 32 UR - https://doi.org/10.1200/JCO.2013.54.8800 DO - 10.1200/JCO.2013.54.8800 ID - Cheson2014 ER - TY - JOUR AU - Kroh, E. M. AU - Parkin, R. K. AU - Mitchell, P. S. AU - Tewari, M. PY - 2010 DA - 2010// TI - Analysis of circulating microRNA biomarkers in plasma and serum using quantitative reverse transcription-PCR (qRT-PCR) JO - Methods VL - 50 UR - https://doi.org/10.1016/j.ymeth.2010.01.032 DO - 10.1016/j.ymeth.2010.01.032 ID - Kroh2010 ER - TY - JOUR AU - Blondal, T. AU - Jensby Nielsen, S. AU - Baker, A. AU - Andreasen, D. AU - Mouritzen, P. AU - WrangTeilum, M. PY - 2013 DA - 2013// TI - Assessing sample and miRNA profile quality in serum and plasma or other biofluids JO - Methods VL - 59 UR - https://doi.org/10.1016/j.ymeth.2012.09.015 DO - 10.1016/j.ymeth.2012.09.015 ID - Blondal2013 ER - TY - JOUR AU - Storey, J. D. PY - 2002 DA - 2002// TI - A direct approach to false discovery rates JO - J R Statist Soc B VL - 64 UR - https://doi.org/10.1111/1467-9868.00346 DO - 10.1111/1467-9868.00346 ID - Storey2002 ER - TY - JOUR AU - Chou, C. H. AU - Chang, N. W. AU - Shrestha, S. AU - Hsu, S. D. AU - Lin, Y. L. AU - Lee, W. H. PY - 2016 DA - 2016// TI - miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database JO - Nucleic Acids Res VL - 44 UR - https://doi.org/10.1093/nar/gkv1258 DO - 10.1093/nar/gkv1258 ID - Chou2016 ER - TY - STD TI - Functional annotation clustering tool DAVID. https://david-d.ncifcrf.gov/. Accessed on 27 October 2017. UR - https://david-d.ncifcrf.gov ID - ref40 ER - TY - STD TI - The Cancer Genome Atlas. https://gdc-portal.nci.nih.gov. Accessed on 11 August 2016. UR - https://gdc-portal.nci.nih.gov ID - ref41 ER - TY - JOUR AU - Fassina, A. AU - Marino, F. AU - Siri, M. AU - Zambello, R. AU - Ventura, L. AU - Fassan, M. PY - 2012 DA - 2012// TI - The miR-17-92 microRNA cluster: a novel diagnostic tool in large B-cell malignancies JO - Lab Investig VL - 92 UR - https://doi.org/10.1038/labinvest.2012.129 DO - 10.1038/labinvest.2012.129 ID - Fassina2012 ER - TY - JOUR AU - Shi, C. AU - Xu, X. PY - 2013 DA - 2013// TI - MicroRNA-22 is down-regulated in hepatitis B virus-related hepatocellular carcinoma JO - Biomed Pharmacother VL - 67 UR - https://doi.org/10.1016/j.biopha.2013.03.002 DO - 10.1016/j.biopha.2013.03.002 ID - Shi2013 ER - TY - JOUR AU - Malumbres, R. AU - Sarosiek, K. A. AU - Cubedo, E. AU - Ruiz, J. W. AU - Jiang, X. AU - Gascoyne, R. D. PY - 2009 DA - 2009// TI - Differentiation stage-specific expression of microRNAs in B lymphocytes and diffuse large B-cell lymphomas JO - Blood VL - 113 UR - https://doi.org/10.1182/blood-2008-10-184077 DO - 10.1182/blood-2008-10-184077 ID - Malumbres2009 ER - TY - JOUR AU - Ono, S. AU - Lam, S. AU - Nagahara, M. AU - Hoon, D. S. PY - 2015 DA - 2015// TI - Circulating microRNA biomarkers as liquid biopsy for Cancer patients: pros and cons of current assays JO - J Clin Med VL - 4 UR - https://doi.org/10.3390/jcm4101890 DO - 10.3390/jcm4101890 ID - Ono2015 ER - TY - JOUR AU - Yu, D. C. AU - Li, Q. G. AU - Ding, X. W. AU - Ding, Y. T. PY - 2011 DA - 2011// TI - Circulating microRNAs: potential biomarkers for cancer JO - Int J Mol Sci VL - 12 UR - https://doi.org/10.3390/ijms12032055 DO - 10.3390/ijms12032055 ID - Yu2011 ER - TY - STD TI - Larrea E, Sole C, Manterola L, Goicoechea I, Armesto M, Arestin M, et al. New concepts in Cancer biomarkers: circulating miRNAs in liquid biopsies. Int J Mol Sci. 2016;17(5):E627. https://doi.org/10.3390/ijms17050627. ID - ref47 ER - TY - JOUR AU - Macha, M. A. AU - Seshacharyulu, P. AU - Krishn, S. R. AU - Pai, P. AU - Rachagani, S. AU - Jain, M. PY - 2014 DA - 2014// TI - MicroRNAs (miRNAs) as biomarker(s) for prognosis and diagnosis of gastrointestinal (GI) cancers JO - Curr Pharm Des VL - 20 UR - https://doi.org/10.2174/1381612820666140128213117 DO - 10.2174/1381612820666140128213117 ID - Macha2014 ER - TY - JOUR AU - Lu, J. AU - Getz, G. AU - Miska, E. A. AU - Alvarez-Saavedra, E. AU - Lamb, J. AU - Peck, D. PY - 2005 DA - 2005// TI - MicroRNA expression profiles classify human cancers JO - Nature VL - 435 UR - https://doi.org/10.1038/nature03702 DO - 10.1038/nature03702 ID - Lu2005 ER - TY - JOUR AU - Ito, K. AU - Okamoto, M. AU - Inaguma, Y. AU - Okamoto, A. AU - Ando, M. AU - Ando, Y. PY - 2016 DA - 2016// TI - Influence of R-CHOP therapy on immune system restoration in patients with B-cell lymphoma JO - Oncology VL - 91 UR - https://doi.org/10.1159/000449251 DO - 10.1159/000449251 ID - Ito2016 ER - TY - JOUR AU - Tanaka, M. AU - Oikawa, K. AU - Takanashi, M. AU - Kudo, M. AU - Ohyashiki, J. AU - Ohyashiki, K. PY - 2009 DA - 2009// TI - Down-regulation of miR-92 in human plasma is a novel marker for acute leukemia patients JO - PLoS One VL - 4 UR - https://doi.org/10.1371/journal.pone.0005532 DO - 10.1371/journal.pone.0005532 ID - Tanaka2009 ER - TY - JOUR AU - Ohshima, K. AU - Inoue, K. AU - Fujiwara, A. AU - Hatakeyama, K. AU - Kanto, K. AU - Watanabe, Y. PY - 2010 DA - 2010// TI - Let-7 microRNA family is selectively secreted into the extracellular environment via exosomes in a metastatic gastric cancer cell line JO - PLoS One VL - 5 UR - https://doi.org/10.1371/journal.pone.0013247 DO - 10.1371/journal.pone.0013247 ID - Ohshima2010 ER - TY - JOUR AU - Valadi, H. AU - Ekström, K. AU - Bossios, A. AU - Sjöstrand, M. AU - Lee, J. J. AU - Lötvall, J. O. PY - 2007 DA - 2007// TI - Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells JO - Nat Cell Biol VL - 9 UR - https://doi.org/10.1038/ncb1596 DO - 10.1038/ncb1596 ID - Valadi2007 ER - TY - JOUR AU - Turchinovich, A. AU - Weiz, L. AU - Burwinkel, B. PY - 2012 DA - 2012// TI - Extracellular miRNAs: the mystery of their origin and function JO - Trends Biochem Sci VL - 37 UR - https://doi.org/10.1016/j.tibs.2012.08.003 DO - 10.1016/j.tibs.2012.08.003 ID - Turchinovich2012 ER - TY - JOUR AU - Healy, N. A. AU - Heneghan, H. M. AU - Miller, N. AU - Osborne, C. K. AU - Schiff, R. AU - Kerin, M. J. PY - 2012 DA - 2012// TI - Systemic mirnas as potential biomarkers for malignancy JO - Int J Cancer VL - 131 UR - https://doi.org/10.1002/ijc.27642 DO - 10.1002/ijc.27642 ID - Healy2012 ER - TY - JOUR AU - Hu, Z. AU - Chen, X. AU - Zhao, Y. AU - Tian, T. AU - Jin, G. AU - Shu, Y. PY - 2010 DA - 2010// TI - Serum microRNA signatures identified in a genome-wide serum microRNA expression profiling predict survival of non-small-cell lung cancer JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.24.9342 DO - 10.1200/JCO.2009.24.9342 ID - Hu2010 ER - TY - JOUR AU - Wang, J. AU - Li, Y. AU - Ding, M. AU - Zhang, H. AU - Xu, X. AU - Tang, J. PY - 2017 DA - 2017// TI - Molecular mechanisms and clinical applications of miR-22 in regulating malignant progression in human cancer (review) JO - Int J Oncol VL - 50 UR - https://doi.org/10.3892/ijo.2016.3811 DO - 10.3892/ijo.2016.3811 ID - Wang2017 ER - TY - JOUR AU - Sibbesen, N. A. AU - Kopp, K. L. AU - Litvinov, I. V. AU - Jønson, L. AU - Willerslev-Olsen, A. AU - Fredholm, S. PY - 2015 DA - 2015// TI - Jak3, STAT3, and STAT5 inhibit expression of miR-22, a novel tumor suppressor microRNA, in cutaneous T-cell lymphoma JO - Oncotarget VL - 6 UR - https://doi.org/10.18632/oncotarget.4111 DO - 10.18632/oncotarget.4111 ID - Sibbesen2015 ER - TY - JOUR AU - Mi, S. AU - Lu, J. AU - Sun, M. AU - Li, Z. AU - Zhang, H. AU - Neilly, M. B. PY - 2007 DA - 2007// TI - MicroRNA expression signatures accurately discriminate acute lymphoblastic leukemia from acute myeloid leukemia JO - Proc Natl Acad Sci U S A VL - 104 UR - https://doi.org/10.1073/pnas.0709313104 DO - 10.1073/pnas.0709313104 ID - Mi2007 ER - TY - JOUR AU - Chang, T. C. AU - Yu, D. AU - Lee, Y. S. AU - Wentzel, E. A. AU - Arking, D. E. AU - West, K. M. PY - 2008 DA - 2008// TI - Widespread microRNA repression by Myc contributes to tumorigenesis JO - Nat Genet VL - 40 UR - https://doi.org/10.1038/ng.2007.30 DO - 10.1038/ng.2007.30 ID - Chang2008 ER - TY - JOUR AU - Zhen, Y. B. AU - Guo, X. L. AU - Xu, B. AU - Zhao, H. W. AU - Xu, C. J. PY - 2016 DA - 2016// TI - Gene expression profiling analysis of the role of miR-22 in clear cell ovarian cancer JO - Neoplasma VL - 63 UR - https://doi.org/10.4149/neo_2016_604 DO - 10.4149/neo_2016_604 ID - Zhen2016 ER - TY - JOUR AU - Suryadinata, R. AU - Sadowski, M. AU - Sarcevic, B. PY - 2010 DA - 2010// TI - Control of cell cycle progression by phosphorylation of cyclin-dependent kinase (CDK) substrates JO - Biosci Rep VL - 30 UR - https://doi.org/10.1042/BSR20090171 DO - 10.1042/BSR20090171 ID - Suryadinata2010 ER - TY - JOUR AU - Georgakilas, A. G. AU - Martin, O. A. AU - Bonner, W. M. PY - 2017 DA - 2017// TI - p21: a two-faced genome Guardian JO - Trends Mol Med VL - 23 UR - https://doi.org/10.1016/j.molmed.2017.02.001 DO - 10.1016/j.molmed.2017.02.001 ID - Georgakilas2017 ER - TY - JOUR AU - Xu, D. AU - Takeshita, F. AU - Hino, Y. AU - Fukunaga, S. AU - Kudo, Y. AU - Tamaki, A. PY - 2011 DA - 2011// TI - miR-22 represses cancer progression by inducing cellular senescence JO - J Cell Biol VL - 193 UR - https://doi.org/10.1083/jcb.201010100 DO - 10.1083/jcb.201010100 ID - Xu2011 ER - TY - JOUR AU - Tsuchiya, N. AU - Izumiya, M. AU - Ogata-Kawata, H. AU - Okamoto, K. AU - Fujiwara, Y. AU - Nakai, M. PY - 2011 DA - 2011// TI - Tumor suppressor miR-22 determines p53-dependent cellular fate through post-transcriptional regulation of p21 JO - Cancer Res VL - 71 UR - https://doi.org/10.1158/0008-5472.CAN-10-2475 DO - 10.1158/0008-5472.CAN-10-2475 ID - Tsuchiya2011 ER - TY - JOUR AU - Pandey, D. P. AU - Picard, D. PY - 2009 DA - 2009// TI - miR-22 inhibits estrogen signaling by directly targeting the estrogen receptor alpha mRNA JO - Mol Cell Biol VL - 29 UR - https://doi.org/10.1128/MCB.01875-08 DO - 10.1128/MCB.01875-08 ID - Pandey2009 ER - TY - JOUR AU - Bar, N. AU - Dikstein, R. PY - 2010 DA - 2010// TI - miR-22 forms a regulatory loop in PTEN/AKT pathway and modulates signaling kinetics JO - PLoS One VL - 5 UR - https://doi.org/10.1371/journal.pone.0010859 DO - 10.1371/journal.pone.0010859 ID - Bar2010 ER - TY - JOUR AU - Xiong, J. AU - Yu, D. AU - Wei, N. AU - Fu, H. AU - Cai, T. AU - Huang, Y. PY - 2010 DA - 2010// TI - An estrogen receptor alpha suppressor, microRNA-22, is downregulated in estrogen receptor alpha-positive human breast cancer cell lines and clinical samples JO - FEBS J VL - 277 UR - https://doi.org/10.1111/j.1742-4658.2010.07594.x DO - 10.1111/j.1742-4658.2010.07594.x ID - Xiong2010 ER -